Cochlear’s Oticon Medical acquisition probed by UK CMA
MLex Summary: Cochlear's planned acquisition of hearing-implants business Oticon Medical from its owner Demant is being probed by the UK Competition and Markets Authority. The CMA will decide by Dec. 6 whether the merger...To view the full article, register now.
Already a subscriber? Click here to view full article